In-vitro Fertilization Market Overview
In-vitro fertilization (IVF) involves the fertilization of ovum using laboratory settings followed by implantation into the uterus. In-vitro fertilization is also known as assisted reproductive technology. The process involves the collection of matured healthy eggs and sperms from the partners or known or anonymous donors. These eggs get fertilized using laboratory reagents & media and instruments. Fertilized eggs (embryos) are implanted into the uterus for the continuation of the development of the embryo to the child. One cycle of in-vitro fertilization takes around 10-15 days. IVF is the most widely accepted method for fertility treatments in the clinical industry and helpful for couples with infertility problems, single mothers, as well as LGBT communities. The major product categories that assist in-vitro fertilization method include reagents & media (such as embryo culture media, sperm processing media) and instruments (sperm separation system, cryosystems).
Growing number of delayed pregnancies among women, rising awareness pertaining to infertility consequences, and the presence of favorable reimbursement systems are driving the growth of the global in-vitro fertilization market. In addition, increasing technological advancements in in-vitro fertilization procedures (embryoscope & capsule in-vitro fertilization), rising medical tourism across the major countries, growing gynecological disorders & fertility disorders, increasing focus of clinical research institutes towards the innovation of in-vitro fertilization technologies, and occurrence of lifestyle disorders (obesity & smoking that favor infertility) are further propelling the growth of the global in-vitro fertilization market. However, requirement of high capital & time for the running of in-vitro fertilization procedures, difficulties to maintain the in-vitro fertilization procedures, chances of occurrence multiple pregnancies, presence of ethical issues pertaining to selection of gender population, and unawareness of infertility issues in certain under-developed economies are restraining the growth of the global in-vitro fertilization market.
In-vitro Fertilization Market Forecast Report (2018-2023)
In-Vitro Fertilization Market is expected to reach USD 5.06 billion by 2023 from USD 2.37 billion in 2018, growing at a CAGR of 16.4% during the forecast period 2018-2023.
In-vitro Fertilization Market Segmentation
Global in-vitro fertilization market is segmented based on reagents & media, instruments, technology, and end users. Based on reagents & media, the market is further sub-segmented as embryo culture media, cryopreservation media, sperm processing media, and ovum processing media. Of these, cryopreservation media accounted for the largest share of the global in-vitro fertilization market by reagents & media in 2018. Based on instruments, the market is segmented as imaging systems, sperm separation systems, ovum aspiration pumps, incubators, micromanipulator systems, cryosystems, and other instruments (gas analyzers, laser systems, accessories). Of these, imaging systems commanded the largest share of the global in-vitro fertilization market by instruments in 2018, whereas, sperm separation systems segment is expected to grow at the highest CAGR during the forecast period 2018-2023
Based on technology, the market is segmented as intra-cytoplasmic sperm injection, pre-implantation genetic diagnosis, frozen embryo transfer/replacement, and other technologies. Among these, intra-cytoplasmic sperm injection segment accounted for the largest share of the global in-vitro fertilization market by technology in 2018. Based on end users, the market is segmented as fertility & surgical centers, hospitals & research laboratories, and cryobanks. Of these, fertility & surgical centers segment commanded the largest share of the global in-vitro fertilization market by end users in 2018.
On the basis of the geographical region, the global in-vitro fertilization market is segmented as North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Europe commanded the highest share of 37.0% of the global in-vitro fertilization market in 2018, whereas Asia-Pacific is estimated to grow at the highest CAGR of 18.40% during the forecast period 2018-2023.
Major Players:
The key players in the global in-vitro fertilization market such as,
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Introduction
5.2 Reagents and Media
5.2.1 Introduction
5.2.2 Embryo Culture Media
5.2.3 Cryopreservation Media
5.2.4 Sperm Processing Media
5.2.5 Ovum Processing Media
5.3 Instruments
5.3.1 Introduction
5.3.2 Imaging Systems
5.3.3 Sperm Separation Systems
5.3.4 Ovum Aspiration Pumps
5.3.5 Incubators
5.3.6 Micromanipulator Systems
5.3.7 Cryosystems
5.3.8 Other Instruments (Gas Analyzers, Laser Systems, Accessories)
5.4 Technology
5.3.1 Introduction
5.3.2 Intra-Cytoplasmic Sperm Injection (ICSI)
5.3.3 Pre-Implantation Genetic Diagnosis (PGD)
5.3.4 Frozen Embryo Transfer/Replacement (FET/FER)
5.3.5 Other Technologies
5.5 End Users
5.4.1 Introduction
5.4.2 Fertility and Surgical Centers
5.4.3 Hospitals and Research Laboratories
5.4.4 Cryobanks
6.1 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.2 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.3 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 Soth Korea
6.4 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.5 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle East
6.5.3 South Africa
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 CooperSurgical, Inc. (U.S.)
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Cook Medical, Inc. (U.S.)
8.3 Irvine Scientific (U.S.)
8.4 Vitrolife AB (Sweden)
8.5 Thermo Fisher Scientific, Inc. (U.S.)
8.6 EMD Serono, Inc. (U.S.)
8.7 Genea Limited (Australia)
8.8 ESCO Micro Pte. Limited (Singapore)
8.9 IVFtech ApS (Denmark)
8.10 The Baker Company, Inc. (U.S.)
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
